2021
DOI: 10.1007/s11255-020-02779-2
|View full text |Cite
|
Sign up to set email alerts
|

Gadolinium-based contrast media exposure and the possible risk of subclinical kidney damage: a pilot study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 20 publications
0
1
0
Order By: Relevance
“…Most researchers agree that the contrast agents used for CT and MRI have different risk profiles for kidney injury. Therefore, the subgroup analysis by the type of imaging examinations (CT/MRI) was performed and the results clarified that the increased risk attributed to exposure iodine-based contrast medium in CT instead of gadolinium-based contrast media, which was consistent with previous findings that gadolinium-based contrast media generally leads to subclinical kidney damage without any significant modification of SCr [6,7]. The aRR for the risk of AKI after exposure to gadolinium-based contrast media was more than 1, although 95% CI included 1, which remand us the potential kidney injury of gadolinium-based contrast did not be ignored.…”
Section: Discussionsupporting
confidence: 84%
See 1 more Smart Citation
“…Most researchers agree that the contrast agents used for CT and MRI have different risk profiles for kidney injury. Therefore, the subgroup analysis by the type of imaging examinations (CT/MRI) was performed and the results clarified that the increased risk attributed to exposure iodine-based contrast medium in CT instead of gadolinium-based contrast media, which was consistent with previous findings that gadolinium-based contrast media generally leads to subclinical kidney damage without any significant modification of SCr [6,7]. The aRR for the risk of AKI after exposure to gadolinium-based contrast media was more than 1, although 95% CI included 1, which remand us the potential kidney injury of gadolinium-based contrast did not be ignored.…”
Section: Discussionsupporting
confidence: 84%
“…However, the impacts of intravenous iodinebased contrast on renal function, including renal tubular epithelial cells damage and hemodynamic perturbations induced by contrast media, are still a research hotspot [2][3][4]. Although initially believed to be without major adverse effects, gadolinium-based contrast agents was demonstrated to cause nephrogenic systemic fibrosis in patients with abnormal renal function [5]; moreover, a recent study indicated that exposure to Gadolinium was related to both necrosis and apoptosis of proximal tubular epithelium which led to kidney injury after Gadolinium exposure [6,7]. A retrospective study found that sequential exposure to iodine-and gadolinium-based contrast media on the same admission was a risk factors for post-contrast acute kidney injury (AKI) [1].…”
Section: Introductionmentioning
confidence: 99%
“…Until the mid-2000s, gadolinium-enhanced magnetic resonance imaging (MRI) was a preferred imaging modality in patients with advanced kidney disease. Although there is some evidence for direct gadolinium nephrotoxicity, current evidence suggests that gadolinium, when used at typical clinical doses, imparts minimal risk for significant AKI (83). However, studies have linked gadolinium-based contrast agents (GBCAs) with the development of nephrogenic systemic fibrosis (NSF), an often debilitating fibrosing disorder of skin, connective tissue, and, in certain cases, internal organs in patients with significantly impaired kidney function (84)(85)(86).…”
Section: Gadolinium-based Contrast and Nephrogenic Systemic Fibrosismentioning
confidence: 99%